Pharmacokinetics and Biopharmaceutics Course 2018

  • Check with publisher
  • Published date: March 6, 2018
    • Baltimore, maryland, United States

Overview:
This seminar is developed with a series of learning objectives in mind. After attending the seminar, the attendees should be able to:
1. Clearly understand the basic concepts of pharmacokinetics and biopharmaceutics.
2. Use raw data and derive the pharmacokinetic models and parameters describing the processes of drug absorption, distribution, and elimination.
3. Apply biopharmaceutics for the products development and manufacturing.
4. Practice in-class hands-on exercises to understand and apply the studied concepts (a computer with excel software would be required).
5. Acquire knowledge of related regulatory/compliance requirements and guidance documents
Why you should attend:
Pharmaceutical product developments and assessments require extensive testing to establish quality, safety and efficacy of the products. Such testing is conducted by laboratory facilities mostly analytical (internal as well as external to the manufacturers) which often lack needed pharmacokinetics and biopharmaceutics expertise/understanding leading to poor study or experimental design followed by inaccurate interpretation of results. Therefore, current practices are not only causing significant frustration and wastage of time and resources within the industry and regulatory authorities but also delays in product approvals. This seminar is designed to address these deficiencies. The attendees will have clear understanding of the underlying science so that they would be able to design/evaluate the experimental studies appropriately followed by efficient and accurate interpretation of the results.
Location: Baltimore, MD Date: April 2nd & 3rd, 2018 and Time: 9:00 AM to 6:00 PM
Venue: WILL BE ANNOUNCED SOON, Baltimore, MD
Price:
Price: $1,295.00 (Seminar Fee for One Delegate)
Register for 5 attendees Price: $3,885.00 $6,475.00 You Save: $2,590.00 (40%)*
Register for 10 attendees Price: $7,122.00 $12,950.00 You Save: $5,828.00 (45%)*
Register now and save $200. (Early Bird)
Until March 10, Early Bird Price: $1,295.00 From March 11 to March 31, Regular Price: $1,495.00

Contact us today!
NetZealous LLC DBA GlobalCompliancePanel
john.robinson@globalcompliancepanel.com
support@globalcompliancepanel.com
Toll free: +1-800-447-9407
Phone: +1-510-584-9661
Website: http://www.globalcompliancepanel.com

Registration Link - https://www.globalcompliancepanel.com/control/globalseminars/~product_id=901678SEMINAR?april-2018-seo-science-marketplace.org
Follow us on LinkedIn: https://www.linkedin.com/company/globalcompliancepanel/
Like us our Facebook page: https://www.facebook.com/TrainingsAtGlobalCompliancePanel/
Follow us on Twitter: https://twitter.com/GCPanel

Result 0 votes
John Robinson
0 votes

Useful information

  • Avoid scams by acting locally or paying with PayPal
  • Never pay with Western Union, Moneygram or other anonymous payment services
  • Don't buy or sell outside of your country. Don't accept cashier cheques from outside your country
  • This site is never involved in any transaction, and does not handle payments, shipping, guarantee transactions, provide escrow services, or offer "buyer protection" or "seller certification"

Related listings

  • Change Control Best Practices - Avoiding Unintended Consequences of Changes

    Change Control Best Practices - Avoiding Unintended Consequences of Changes

    Pharmacology - Drug Development san Jose (california) December 18, 2020 Check with publisher

    One of the top 10 FDA 483 and Warning Letter citations is for inadequate change control. Change control receives detailed scrutiny during FDA inspections, and FDA reviews change control documentation to determine that changes did not adversely impact...

  • Data Integrity: FDA/EU Requirements and Implementation

    Data Integrity: FDA/EU Requirements and Implementation

    Pharmacology - Drug Development san Jose (california) December 18, 2020 Check with publisher

    Data integrity has been a focus for pharmaceutical regulatory inspections for a number of years and look set to remain of concern to regulators and manufacturers for many years to come. Many inspection reports from regulatory agencies around the worl...

  • Assess Impact For Supplier Change Notices

    Assess Impact For Supplier Change Notices

    Pharmacology - Drug Development san Jose (california) December 12, 2020 Check with publisher

    This webinar will discuss dealing with supplier change notices. Regulatory agencies have the expectation that a manufacturer has control over its supply chain and dealing with changes to that supply chain can be challenging.